ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2346

Specific Overexpression of FPR2 (FPRL-1) on Th1 Cells in GPI-Induced Arthritis and Patients with Rheumatoid Arthritis

Yuki Tanaka1, Isao Matsumoto2, Asuka Inoue3, Naoto Umeda4, Chinatsu Takai5, Yuko Kurashima6, Hoshimi Kawaguchi6 and Takayuki Sumida7, 1Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba city, Ibaraki, Japan, 2Department of Interenal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 3Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, University of Tsukuba, Tsukuba city, Ibaraki, Japan, 4Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba City, Japan, 5University of Tsukuba, Ibaraki, Japan, 6University of Tsukuba, Tsukuba, Japan, 7Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: animal models and rheumatoid arthritis (RA), T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Animal Models

Session Type: Abstract Submissions (ACR)

【Background/Purpose 】

CD4+T cell are critical to the pathogenesis of rheumatoid arthritis (RA).  In glucose-6-phosphate isomerase (GPI) induced-arthritis (GIA), Th1 and Th17 cells are indispensable for both the induction and the effector phase. We recently identified the highly expression of formyl peptide receptor 2 (FPR2) in splenic CD4+T cells from GIA mice by DNA microarray. The FPR2 (human homologue: FPRL-1) is a G-protein coupled receptor showing pro- and anti-inflammatory effect. To clarify the function of FPR2 in CD4+ T cells in the generation of arthritis, we investigated the expression of FPR2 in GIA and FPRL-1 in patients with RA.

【Methods 】 

(1)   To confirm the results of DNA microarray, we analyzed the fluctuated expression of FPR2 mRNA on CD4+T cells in GIA (day0, day 7: induction phase, day 14: effector phase, day 28: contraction phase) by real-time PCR.

(2)   To determine the Th subsets expressing FPR2, we sorted FPR2+ or FPR2– CD4+T cells from lymph nodes of GIA (on day7), and the mRNA expression of various markers on CD4+T cell subsets (Th1, 2, 17, Tfh and Treg) was examined.

(3)   We analyzed the expression of FPR2 on Th1 or Th17 cells in the polarized condition in vitro.

(4)   In human, we analyzed the expression of FPRL-1 mRNA on peripheral blood mononuclear cells (PBMC) and CD4+T cells from healthy subjects (HS), patients with Sjogren’s syndrome (SS), and RA patients.

(5)   We assessed the expression of FPRL-1 on human Th1 cells in the polarized condition in vitro.

【Results 】

(1)    The FPR2 mRNA was significantly highly expressed on CD4+T cells in GIA on day7 (p<0.05).

(2)    The T-bet and IFNγ were higher expressed on FPR2+CD4+T cells than those on FPR2–CD4+T cells, whereas each marker for Th2, Th17, Tfh and Treg cells were not.

(3)    The expression of FPR2 was frequently detected on Th1 polarized cells, but not on Th17 polarized cells.

(4)    The expression of FPRL-1 on PBMC and CD4+ cells was significantly higher in RA compared with HS and SS (p<0.05).

(5)    FPRL-1 expression was significantly increased on human Th1 polarized cells.

【Conclusion 】

We identified that FPR2+T cells showed Th1 phenotype in mice and FPRL-1 was highly detected on CD4+T cells in patients with RA. Th1 polarized cells in mice and humans also expressed FPR2 and FPRL-1, respectively, suggesting FPR2+ (FPRL-1+) T cells might play a crucial role in the pathogenesis of RA.


Disclosure:

Y. Tanaka,
None;

I. Matsumoto,
None;

A. Inoue,
None;

N. Umeda,
None;

C. Takai,
None;

Y. Kurashima,
None;

H. Kawaguchi,
None;

T. Sumida,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/specific-overexpression-of-fpr2-fprl-1-on-th1-cells-in-gpi-induced-arthritis-and-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology